Quantcast
Public-private Partnership Funds 115M In Biophysics Cancer

Public-private Partnership Funds $11.5M In Biophysics Cancer Research

National Science Foundation A new public-private partnership between the National Science Foundation (NSF), National Cancer Institute (NCI), Stand Up To Cancer (SU2C) and The V Foundation for Cancer Research is committing $11.5 million towards...

Latest Cancer Research Stories

2014-09-17 00:20:34

Article in Baltimore Sun WASHINGTON, Sept. 16, 2014 /PRNewswire-USNewswire/ -- George Washington University cancer researcher Dr. Patricia Berg, former White House Drug Policy Spokesman and House Aging Committee Director Robert Weiner, and Solutions for Change Senior Policy Analyst Tom Sherman, are asserting that Federal cancer research funding cuts are threatening the nation's mortality rate. The trio wrote an article, "FUND CANCER RESEARCH TO KEEP BREAKTHROUGHS COMING," which...

2014-09-16 23:15:45

Seattle’s own Cancer Research And Biostatistics (CRAB), and Translational Drug Development (TD2) in Scottsdale, would like to jointly announce CRAB’s assumption of responsibility for the PCRT, a world-renowned consortium comprised of a team of pancreatic cancer experts committed to improve treatment outcomes for patients with this deadly cancer. Seattle, WA (PRWEB) September 16, 2014 Seattle’s own Cancer Research And Biostatistics (CRAB), and Translational Drug Development (TD2) in...

2014-09-15 23:11:36

A collaborative study between researchers at the University of Colorado Cancer Center and the National Cancer Institute (NCI) published today in the journal Clinical Cancer Research takes an important step toward answering the question: which altered genes are most to blame for bladder cancer? AURORA, Colo. (PRWEB) September 15, 2014 The story of cancer care seems so simple: find the mutated gene that causes cancer and turn it off or fix it. But rarely does a single gene cause cancer....

2014-09-15 16:28:12

Multidisciplinary team composed of six organizations awarded $20,000 for groundbreaking work in mesothelioma and non-small cell lung cancer SYDNEY, Sept. 15, 2014 /PRNewswire/ -- EnGeneIC, Ltd., an emerging biopharmaceutical company focused on revolutionizing the treatment of cancer through the targeted delivery of therapeutic agents directly to cancer cells, announced that, together with the Asbestos Disease Research Institute (ADRI), it has received the 2014 Cancer Institute New...

2014-09-12 12:24:46

Founding partner Equinox and their instructors will lead participants on stationary bikes to support rare cancer research led by Memorial Sloan Kettering Cancer Center, which owns and operates Cycle for Survival. NEW YORK, Sept. 12, 2014 /PRNewswire/ -- Cycle for Survival, the nationwide movement to beat rare cancers, will bring hundreds of supporters to Times Square on September 19 for the second annual Times Square Takeover, an all-day celebration featuring high-energy stationary...

2014-09-11 12:27:08

Medical Community Members and Locals Honored For Their Tireless Support For The Cause And Ongoing Fight For A Cure WASHINGTON, Sept. 11, 2014 /PRNewswire-USNewswire/ -- Voices Against Brain Cancer is set to host its inaugural annual "Join the Voices! D.C. Walk." On Sunday, September 21, 2014 The National Mall will be filled with individuals, friends, family and loved ones joined together in support of this worthy cause. Registration begins at 8:00 AM with a 9:00 AM start time. The...

2014-09-11 12:25:14

American Businesswoman, Writer and Television Personality Appears in Public Service Announcements for QVC Presents "FFANY Shoes on Sale" WEST CHESTER, Pa., Sept. 11, 2014 /PRNewswire/ -- When it comes to a great pair of shoes, Ivanka Trump is an expert. As a successful businesswoman and entrepreneur, she knows that power shoes can help a woman feel like she is ready to conquer the world. This year, Trump is digging in her heels to help fight breast cancer through her involvement with...

2014-09-11 08:27:28

-Conference Call and Webcast on September 12, 2014 at 8:30 a.m. ET, 5:30 a.m. PT- MENLO PARK, Calif. and LONDON, Sept. 11, 2014 /PRNewswire/ -- CANCER RESEARCH UK and Cancer Research Technology (CRT), the charity's development and commercialisation arm, have reached an agreement with Asterias Biotherapeutics, Inc. (OTCBB: ASTY), a biotechnology company in the emerging field of regenerative medicine, to take forward Asterias' novel immunotherapy treatment AST-VAC2 into clinical trials in...

2014-09-10 16:26:49

NEW YORK, Sept. 10, 2014 /PRNewswire/ -- Uniting Against Lung Cancer (UALC) is pleased to announce a new partnership with The Hearst Foundation, Inc. supporting lung cancer research through UALC's esteemed Scientific Program. Since 2003, UALC has funded over $11.5 million to support groundbreaking, innovative lung cancer research at the nation's leading cancer centers and hospitals. This investment has resulted in over $57 million in follow-on funding, new researchers entering the...

2014-09-10 16:25:08

Stage set to determine if drugs called tyrosine kinase inhibitors will extend the lives of patients with the high-risk acute lymphoblastic leukemia subtype; pediatric clinical trial scheduled to open by early 2015 MEMPHIS, Tenn., Sept. 10, 2014 /PRNewswire-USNewswire/ -- More than one-quarter of young adults with the most common form of acute lymphoblastic leukemia (ALL) have a high-risk subtype with a poor prognosis and may benefit from drugs widely used to treat other types of...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related